BBSRC Portfolio Analyser
Award details
Novel targets for vaccine development and immunotherapy to combat Staphylococcus aureus and other pathogens
Reference
BB/D525748/1
Principal Investigator / Supervisor
Professor Simon J. Foster
Co-Investigators /
Co-Supervisors
Institution
University of Sheffield
Department
Molecular Biology and Biotechnology
Funding type
Research
Value (£)
59,703
Status
Completed
Type
Research Grant
Start date
01/04/2006
End date
31/03/2007
Duration
12 months
Abstract
Antibiotic resistant, pathogenic bacteria are a constant and increasing threat. An important alternative to antibiotics is disease prevention by vaccination and the use of therapeutic antibodies. The project will develop a new class of vaccine/antibody targets against the superbug Staphylococcus aureus and other infectious microbes. The targets are those which are essential for the life of the cell and so the bacterium cannot do without them. Our BBSRC funded work has identified suitable novel targets in S. aureus and has shown them to be accessible to the immune system. A patent has been filed by the University of Sheffield to protect this finding. For further exploitation and commercialisation the essential components need to be produced and their potential as vaccine constituents examined. Concomitant with scientific advances a commercial structure will be established to allow the full potential of the area to be realised.
Summary
unavailable
Committee
Closed Committee - Plant & Microbial Sciences (PMS)
Research Topics
X – not assigned to a current Research Topic
Research Priority
X – Research Priority information not available
Research Initiative
Follow-On Fund (FOF) [2004-2015]
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search